Priyatham Kasaraneni

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Metastatic Renal Cell Carcinoma

End Stage Renal Disease

Prognostic Factors

Ejection Fraction

Top Venues

Indian journal of cancer

Arab journal of urology

This page only lists publications with an associated author ORCID identifier.

Publications

Jiten Jaipuria, Ankita Jain, Shashikant Gupta, Nripesh Sadasukhi, Priyatham Kasaraneni, Amitabh Singh, Kush Gupta, Girish Sharma, Vineet Talwar, Sudhir Kumar Rawal
jomfp2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience. Indian journal of cancer (2024)
Jiten Jaipuria, Ankita Jain, Shashikant Gupta, Nripesh Sadasukhi, Priyatham Kasaraneni, Amitabh Singh, Kush Gupta, Girish Sharma, Vineet Talwar, Sudhir Kumar Rawal
2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience. Indian journal of cancer 60 (4) (2024)
Jiten Jaipuria, Ankita Jain, Shashikant Gupta, Nripesh Sadasukhi, Priyatham Kasaraneni, Amitabh Singh, Kush Gupta, Girish Sharma, Vineet Talwar, Sudhir Kumar Rawal
2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience. Indian journal of cancer 60 (4) (2024)
Jiten Jaipuria, Ankita Jain, Shashikant Gupta, Nripesh Sadasukhi, Priyatham Kasaraneni, Amitabh Singh, Kush Gupta, Girish Sharma, Vineet Talwar, Sudhir Kumar Rawal
2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience. Indian journal of cancer (2024)
Sandeep Puvvada, Priyatham Kasaraneni, Ramesh Desi Gowda, Prasad Mylarappa, Manasa T, Kanishk Dokania, Abhishek Kulkarni, Vivek Jayakumar
Stepwise approach in the management of penile strangulation and penile preservation: 15-year experience in a tertiary care hospital. Arab journal of urology 17 (4) (2019)